Global Biological Drugs Market to be Worth US$287,139.7

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Global Biological Drugs Market to be Worth US$287,139.7 Million by 2020: Transparency Market Research

Albany, NY, Oct. 20, 2014 (GLOBE NEWSWIRE) -- Transparency Market Research, in its latest report, states that the global biological drugs market was worth US$161,056.5 million in 2014 and is expected to grow to US$287,139.7 million by 2020 at a CAGR of 10.1% from 2014 to 2020. The report, titled ' Biological Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020 ', provides a historic background of the biological drugs market. According to figures mentioned in the report, the market for biological drugs was worth US$101,656.5 million in 2009 and reached a value of US$146,548.2 million by 2013 at a 9.6% CAGR during the period.

Browse full Global Biological Drugs Market report with complete TOC : http://www.transparencymarketresearch.com/bio...arket.html

Biological drugs are used in the treatment and prevention of diseases such as Alzheimer's disease, HIV/AIDS, cancer, asthma, inflammatory diseases, rheumatoid arthritis, diabetes, and irritable bowel syndrome. A growing geriatric population translates into wider prevalence of various diseases. As a result, the demand for biological drugs is on the rise. Moreover, the promotion of biological drugs by government organizations and advances in the field of biomedical science hold immense scope for future growth of the biological drugs market.

Browse Press Release of Biological Drugs Market : http://www.transparencymarketresearch.com/pre...market.htm

North America is the largest market owing to increased use of biological drugs for the treatment and prevention of various diseases and growing government aid. The biological drugs market in Europe too has witnessed significant and rapid growth due to the same reasons. The Asian biological drugs market has been attracting numerous vendors with its low-cost biological drugs manufacturing alternatives. Furthermore, with the help of government support, the quantity and quality of R&D activities and construction of facilities in biotech companies has increased, boosting the biological drugs market in Asia.

Related and Recently Published Reports by Transparency Market Research :

In contrast, adverse effects of biologic injectable drugs, patent expiry of leading drugs and high cost of biological drugs is expected to hamper the growth of the biological drugs market. However, these same factors hold immense potential for improvement. Costly drugs will offer opportunities to vendors to develop cheaper alternatives of biological drugs. Similarly, patent expiry of top drugs will allow new and emerging manufactures to take their place.

The report segments the overall biological drugs market on the basis of therapeutic protein, monoclonal antibody (mAb), vaccine, and geography. Among all biological drugs of the therapeutic protein segment, Enbrel has the largest and most rapidly growing market. While Prevnar 13 was the fastest-growing and largest segment among biological drugs vaccines, Humira accounted for the maximum market share of the mAb segment and was also the fastest-growing mAb.

For further inquiries, ask here : http://www.transparencymarketresearch.com/sam...ep_id=1694

The global biological drugs market is highly competitive and there are many leading and emerging players operating in the industry. Some of the prominent biological drugs manufacturers include Baxter International Inc., Abbott Laboratories, Eli Lilly and Company, GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Biogen Idec, and Pfizer Inc.

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

CONTACT: Sheela AK State Tower, 90 State Street,Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA/Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Web: http://www.transparencymarketresearch.com/ Blog: http://www.tmrblog.com/ Blog: http://transparencymarketresearch.areavoices.com/

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sola's 11-Step Push Makes Salon Ownership Less Blind

Updated Category News Views 227

A pristine studio does not pay rent by itself. That is the uncomfortable little truth sitting underneath Sola Salons’ new 11-step roadmap for beauty professionals considering salon-suite ownership. The company is telling stylists, estheticians, nail technicians, massage therapists, and other independent operators to treat the move from commission work to ownership like...

Continue Reading
VeriSilicon's New AI/AR Glasses Tech: Game-Changer?

Updated Category News Views 125

VeriSilicon Unveils Next-Generation Subsystem There's some sizzle in the air with VeriSilicon's latest move in the wearable tech arena. They’ve launched a low-power, high-performance subsystem aimed squarely at AI and augmented reality glasses. Now, these gizmos aren't just the stuff of science fiction. Thanks to their Nano-XR series, reality might just get a splash...

Continue Reading
FULC, DSGR and OPCH Deals Draw Fresh Shareholder Scrutiny

Updated Category News Views 22

Three proposed transactions have drawn the kind of legal glare that makes shareholders sit up and check the fine print twice. On November 18, 2026, Halper Sadeh LLC said it was investigating deals involving Fulcrum Therapeutics, Distribution Solutions Group, and Option Care Health for possible federal securities-law violations or fiduciary-duty breaches. That is not a...

Continue Reading
MacDill Mold Case Puts Privatized Housing on Notice

Updated Category News Views 58

Four hundred fifty-four people are a hard number to shrug off. The expanded civil case over alleged toxic mold conditions at MacDill Air Force Base now covers 105 military families, up from 39 households when it was filed in September 2025. Their complaint against The Michaels Organization and affiliated entities may be the largest known military-housing lawsuit in the...

Continue Reading
Avelo Tests Loyalty Math With WeSalute Fare Discounts

Updated Category News Views 255

Airline discounts can look like generosity until the load factor starts talking back. Avelo Airlines has joined WeSalute with fare discounts for active-duty military members, veterans, first responders, nurses, medical professionals, public servants, teachers and eligible family members. It is a sensible move for a young carrier built around smaller airports and lower...

Continue Reading
Floating Solar Gets a Serious Test in Central New York

Updated Category News Views 99

A flooded quarry pit outside Cortlandville is getting a second career, and that is more interesting than another solar announcement draped across empty acreage. Third Pillar Power has started construction on Crown City Solar at Suit-Kote Corporation's active Polkville Crushed Stone Facility, pairing a working mine, asphalt plant, and storage terminal with what the...

Continue Reading
Mike Blyth’s Hall of Fame Honors a Builder’s Legacy

Updated Category News Views 147

Recognition earned in the hangar, not a boardroom Aircraft design has a ruthless way of exposing empty talk, which is why Mike Blyth’s November 11 induction into the EAA Homebuilders Hall of Fame carries real weight. The Experimental Aircraft Association’s honor, presented in the Eagle Hangar at the EAA Aviation Museum in Oshkosh, Wisconsin, recognizes a career built...

Continue Reading
MAXHUB's Canon Office Test Puts Hybrid Work on Trial

Updated Category News Views 32

Thirty-nine devices scattered through a new Hong Kong office may not sound earth-shaking, but this is how workplace technology actually earns its keep: not under trade-show lights, but when somebody is late to a meeting in another time zone and the room has to work anyway. MAXHUB and Canon Hong Kong have launched the first officially delivered Co-Create 100 project...

Continue Reading
TYYY Liquidation Leaves Holders With a Tight Exit Window

Updated Category News Views 200

A fund can vanish faster than investors can read the fine print, and TYYY is doing exactly that. Exchange Traded Concepts has approved the closure and liquidation of the xETFs TSLA Daily Income ETF, with the fund expected to cease operations and distribute cash on or about November 20, 2026. This is not a debate about whether holders should love or hate Tesla. The product...

Continue Reading
CD Rates Offer Stillness as Stocks and Gold Wobble

Updated Category News Views 111

November has delivered the sort of tape that makes a supposedly diversified portfolio feel like a leaky boat. Stocks fell sharply, gold slid to a one-year low after record highs as recently as January, and Treasuries have not provided the dependable ballast many investors expected. When inflation worries and federal-debt concerns shove yields higher, bond prices can drop...

Continue Reading

Top 5 Most Recently Viewed Articles

Surfx Sues ONTOS Over Patent Breach in Plasma Tech

Updated Category News Views 55

Surfx's Legal Gambit: A Staunch Defense of Innovation Surfx Technologies, LLC has taken a bold step by filing a federal lawsuit against ONTOS Equipment Systems, Inc. for allegedly infringing on its patents. It's no walk in the park when your cutting-edge plasma systems are at stake. With busy players in the semiconductor, aerospace, and medical device markets, Surfx isn't...

Continue Reading
GeneDx Faces Securities Fraud Suit Over Fabric Deal

Updated Category News Views 82

Trouble in Paradise: GeneDx's Post-Acquisition Blues Ever get that feeling you’ve been handed a lemon? Well, GeneDx Holdings Corp. (NASDAQ: WGS) seems to be in that very predicament with their acquisition of Fabric Genomics. A deal meant to expand markets now casts a long shadow, and the aftermath is stirring up a securities fraud class action lawsuit. If you dipped...

Continue Reading
Insights on the Growing Aluminum Composite Material Market

Updated Category News Views 191

Understanding the Aluminum Composite Material Market The aluminum composite material (ACM) market is witnessing exciting developments as it is projected to reach USD 10.93 billion by 2034, growing at a CAGR of 6.99%. The demand for aluminum composite materials is increasing due to their lightweight properties, durability, and versatility. These materials are primarily...

Continue Reading
Preeclampsia Diagnostics Market Set for Growth Beyond 2032

Updated Category News Views 158

Overview of Preeclampsia Diagnostics Market The Preeclampsia Diagnostics Market is poised to experience significant growth, driven largely by the increasing prevalence of preeclampsia and enhanced awareness among expectant mothers and healthcare professionals. This growth is fueled by innovative product developments from leading companies within the industry and...

Continue Reading
Inszone Insurance Services Expands with Southerland Acquisition

Updated Category News Views 266

Inszone Insurance Services Expands Its Texas Reach Inszone Insurance Services, a leading provider of commercial, personal, and benefits insurance, is excited to announce its recent acquisition of Southerland and Associates, Inc. This move not only solidifies Inszone's presence in Texas but also enhances its capacity to deliver personalized and diverse insurance solutions...

Continue Reading